NSE: LUPIN | BSE: 500257

Mid-range Performer

Download real time

1963.50 -27.40 (-1.38%)

1.4M NSE+BSE Volume

High volume today

NSE 25 Sep, 2025 3:31 PM (IST)

89,684.4

Market Cap

High in industry

0.9

Beta 1Year

Low volatility

US FDA Approval

Lupin gets US FDA tentative nod for its ANDA for HIV treatment tablets with a market size of $16 bn See details

Lupin Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for LUPIN, BSE:500257 Lupin Ltd.

Is Lupin Ltd. worth buying?

923 Votes:

Buy 72.81%

Sell 17.44%

Hold 9.75%

RESEARCH REPORTS

Buy SEE REPORTS >

Hold SEE REPORTS >